Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing

Antisense oligonucleotide (ASO)-based therapy is one of the next-generation therapy, especially targeting neurological disorders. Many cases of ASO-dependent gene expression suppression have been reported. Recently, we developed a tocopherol conjugated DNA/RNA heteroduplex oligonucleotide (Toc-HDO)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nucleic Acids Res
Main Authors: Asada, Ken, Sakaue, Fumika, Nagata, Tetsuya, Zhang, Ji-chun, Yoshida-Tanaka, Kie, Abe, Aya, Nawa, Makiko, Nishina, Kazutaka, Yokota, Takanori
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Chemical Biology and Nucleic Acid Chemistry
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8136785/
https://ncbi.nlm.nih.gov/pubmed/33928345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkab258
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados